Jump Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jump Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,000	Closed	-$948K	–	2083
2025 Q4	$948K	Sell	29,000 -22,300	-43%	-$720K	0.01%	989
2025 Q3	$1.78M	Buy	51,300 +26,570	+107%	+$850K	0.02%	774
2025 Q2	$692K	Buy	+24,730	New	+$663K	0.01%	1113
2021 Q4	–	Sell	-29,817	Closed	-$1.57M	–	1507
2021 Q3	$1.57M	Buy	29,817 +19,846	+199%	+$1.18M	0.11%	202
2021 Q2	$687K	Buy	9,971 +5,516	+124%	+$421K	0.07%	374
2021 Q1	$343K	Buy	+4,455	New	+$410K	0.03%	563

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial's LKFT Position: Q1 2026 in Review

Jump Financial sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 29,000 shares — an estimated $948K sold.

Jump Financial first reported a position in LKFT in Q1 2021 and held it in 6 quarters. The position peaked at $1.78M in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Jump Financial reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 29,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $948K.
Jump Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 6 quarters.
Jump Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.78M in Q3 2025.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.